Inhibitors of Tyrosine Kinases in the Treatment of Psoriasis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|6|9|933-942

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.6, Iss.9, 2000-06, pp. : 933-942

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dual Inhibitors of Src and Abl Tyrosine Kinases

By  

Drug Design Reviews - Online, Vol. 1, Iss. 3, 2004-07 ,pp. : 203-214

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Aurora kinases for the treatment of cancer

By Fancelli Daniele   Moll Jürgen  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 9, 2005-09 ,pp. : 1169-1182

Informa Healthcare

Access to resources Recommend Favorite

Therapeutically Targeted Anticancer Agents: Inhibitors of Receptor Tyrosine Kinases

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 3, 2004-03 ,pp. : 273-283

Bentham Science Publishers

Access to resources Recommend Favorite

Last Findings on Dual Inhibitors of Abl and Src Tyrosine-Kinases

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 2, 2007-02 ,pp. : 191-201

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of Clinical Resistance to Small Molecule Tyrosine Kinase Inhibitors Targeting Oncogenic Tyrosine Kinases

By Heiko van der Kuip  

American Journal of PharmacoGenomics, Vol. 5, Iss. 2, 2005-01 ,pp. : 101-112

Adis International

Access to resources Recommend Favorite